Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits

Veterinary Journal

Volumn 174, Issue 1, 2007, Pages 154-159

  Cárceles, Carlos M ^a   Fernández Varón, Emilio ^a   Marín, Pedro ^a   Escudero, Elisa ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Azithromycin; Disposition; Half life; Rabbits; Tissue

Indexed keywords

AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BILE; BIOASSAY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG RETENTION; DRUG TISSUE LEVEL; FEMALE; HEART; KIDNEY PARENCHYMA; LUNG PARENCHYMA; MALE; NONHUMAN; RABBIT; SINGLE DRUG DOSE; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; AZITHROMYCIN; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; RABBITS; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS;

EID: 34249871937     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2006.05.022     Document Type: Article

References (27)

1. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T., and Sunderland S.J. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 203-210
2. Carbon C. Pharmacokinetics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. Clinical Infectious Diseases 27 (1998) 28-32
3. Cars O. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scandinavian Journal of Infectious Diseases 74 (1991) 23-33
4. Coke R.L., Hunter R.P., Isaza R., Koch D.E., Goatley M.A., and Carpenter J.W. Pharmacokinetics and tissue distribution of azithromycin in ball pythons (Python regius). American Journal of Veterinary Research 64 (2003) 225-228
5. Davila D., and Kolacny-Babic L. Pharmacokinetics of azithromycin after single oral dosing of experimental animals. Biopharmaceutics and Drug Disposition 12 (1991) 505-514
6. Davis J.L., Gardner S.Y., Jones S.L., Schwabenton B.A., and Papich M.G. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 99-104
7. Dudley M.N., and Ambrose P.G. Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time. Current Opinion in Microbiology 3 (2000) 515-521
8. Dunn C.J., and Barradel L.B. Azithromycin: a review of its pharmacological properties and use as 3-day therapy in respiratory tract infection. Drugs 51 (1996) 483-505
9. Escudero, E., Fernández-Varón, E., Mari{dotless}́n, P., Espuny, A., Najera, M.D., Cárceles, C.M., 2006. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits. Research in Veterinary Science. d.o.i: 10.1016/j.rvsc.2006.01.006.
10. Foulds G., and Johnson R.B. Selection of dose regimens of azithromycin. Journal of Antimicrobial Chemotherapy 31 (1993) 39-48
11. Foulds G., Shepard R.M., and Johnson R.B. The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 25 (1990) 73-82
12. Gibaldi, M., Perrier, D., 1982. Dosificación múltiple. In: Farmacocinética, Editorial Reverté, Barcelona, Spain, pp. 99-131.
13. Girard A.E., Girard D., English A.R., Gootz T.D., Cimochowski C.R., Faiella J.A., Haskell S.L., and Retsema J.A. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993) a new macrolide with extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy 31 (1987) 1948-1954
14. Girard A.E., Girard D., and Retsema J.A. Correlation of extravascular pharmacokinetics of azithromycin with in-vivo efficacy models of localized infection. Journal of Antimicrobial Chemotherapy 25 (1990) 61-71
15. Goldstein E.J.C., Citron D.M., Merriam C.V., Warren Y., and Tyrrel K. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. Antimicrobial Agents and Chemotherapy 44 (2000) 2525-2529
16. Hunter R.P., Lynch M.J., Ericson J.F., Millas W.J., Fletcher A.M., Ryan N.I., and Olson J.A. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 38-46
17. Lalak N.J., and Morris D.L. Azithromycin clinical pharmacokinetics. Clinical Pharmacokinetics 25 (1993) 370-374
18. Lode H., Borner K., Koeppe P., and Schaberg T. Azithromycin - Review of key chemical, pharmacokinetics and microbiological features. Journal of Antimicrobial Chemotherapy 37 (1996) 1-8
19. McDonald P.J., and Pruul H. Macrolides and the immune system. Scandinavian Journal of Infectious Diseases 83 (1992) 34-40
20. Nowakowski M.A., Inskeep P.B., Risk J.E., Skogerboe T.L., Benchaoui H.A., Meinert T.R., Sherington J., and Sunderland S.J. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new tiamilide antibiotic, in cattle. Veterinary Therapeutics 5 1 (2004) 60-74
21. Peters D.H., Friedel H.A., and McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 44 (1992) 750-799
22. Retsema J.A., Bergeron J.M., Girard D., Milisen W.B., and Girard A.E. Preferential concentration of azithromycin in an infected mouse thigh model. Journal of Antimicrobial Chemotherapy 31 Suppl. E (1993) 5-16
23. Rodvold K.A., Gotfried M.H., Danziger L.H., and Servi R.J. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrobial Agents and Chemotherapy 41 (1997) 1399-1402
24. Shargel L., and Yu A.B.C. Multiple-dosage regimens. Applied Biopharmaceutics and Pharmacokinetics (1993), Prentice Hall International, London, UK 353-374
25. Shepard R.M., and Falkner F.C. Pharmacokinetics of azithromycin in rats and dogs. Journal of Antimicrobial Chemotherapy 25 (1990) 49-60
26. Stamler D.A., Edelstein M.A.C., and Edelstein P.H. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. Antimicrobial Agents and Chemotherapy 38 (1994) 217-222
27. Toutain P.L., and Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 467-477